Variable | Positive N = 35 n (%) | Negative N = 43 n (%) | Unable to produce N = 15 n (%) | Others N = 3 n (%) | Total | X2 | p Value |
Age | |||||||
<20 | 1 (2.8) | 9 (20.9) | 13 (86.7) | 1 (33.1) | 24 (24.7) | 48.156 | 0.000* |
20 - 29 | 5 (13.9) | 5 (11.6) | 0 (0.0) | 0 (0.0) | 10 (10.3) |
|
|
30 - 39 | 15 (41.7) | 16 (37.2) | 1 (6.7) | 1 (33.3) | 33 (34.0) |
|
|
40 - 49 | 13 (5.6) | 8 (18.6) | 1 (6.7) | 0 (0.0) | 22 (227) |
|
|
−50 - 59 | 2 (5.6) | 4 (9.3) | 0 (0.0) | 1 (33.3) | 7 (7.2) |
|
|
60 - 69 | 0 (0.0) | 1 (2.3) | 0 (0.0) | 0 (0.0) | 1 (1.0) |
|
|
Weight | |||||||
<20 | 0 (0.0) | 1 (2.3) | 11 (73.3) | 0 (0.0) | 12 (12.4) | 77.767 | 0.000* |
20 - 29.9 | 0 (0.0) | 5 (11.6) | 1 (6.7) | 1 (33.3) | 7 (7.2) |
|
|
30 - 39.9 | 1 (2.8) | 3 (7.0) | 0 (0.0) | 0 (0.0) | 4 (4.1) |
|
|
40 - 49.9 | 7 (2.8) | 12 (27.9) | 2 (13.3) | 1 (33.3) | 22 (22.7) |
|
|
50 - 59.9 | 14 (38.9) | 13 (30.2) | 1 (6.7) | 0 (0.0) | 28 (28.9) |
|
|
60 - 69.9 | 9 (25.0) | 6 (14.0) | 0 (0.0) | 1 (33.3) | 16 (16.5) |
|
|
70 - 79.9 | 5 (13.9) | 2 (4.7) | 0 (0.0) | 0 (0.0) | 7 (7.2) |
|
|
Residence | |||||||
Urban | 21 (58.3) | 27 (62.6) | 9 (60.0) | 3 (100.0) | 60 (61.9) | 2.077 | 0.557 |
Rural | 15 (51.7) | 16 (37.2) | 6 (40.0) | 0 (0.0) | 37 (38.1) |
|
|
Site of disease | |||||||
Pulmonary | 36 (100.0) | 38 (88.4) | 13 (86.7) | 3 (100.0) | 90 (92.8) | 5.121 | 0.163 |
Extrapulmonary | 0 (0.0) | 5 (11.6) | 2 (13.3) | 0 (0.0) | 7 (7.2) |
|
|
Antiretroviral treatment status | |||||||
On treatment: | 20 (55.6) | 21 (48.8) | 3 (20.0) | 1 (33.3) | 45 (46.4) | 5.726 | 0.126 |
Not on treatment | 16 (44.4) | 22 (51.2) | 12 (80.0) | 2 (66.7) | 52 (53.6) |
|
|
Treatment Regimen | |||||||
Category 1: | 34 (94.4) | 41 (95.3) | 15 (100.0) | 3 (100.0) | 93 (95.9) | 0.991 | 0.803 |
Category 2: | 2(5.6) | 2(4.7) | 0(0.0) | 0(0.0) | 4(4.1) |
|
|